- Home
- Publications
- Publication Search
- Publication Details
Title
Statins improve NASH via inhibition of RhoA and Ras
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
Volume 311, Issue 4, Pages G724-G733
Publisher
American Physiological Society
Online
2016-09-16
DOI
10.1152/ajpgi.00063.2016
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Liver fat, statin use, and incident diabetes: The Multi-Ethnic Study of Atherosclerosis
- (2015) Ravi V. Shah et al. ATHEROSCLEROSIS
- Statins, Rho GTPases and KLF2: new mechanistic insight into liver fibrosis and portal hypertension
- (2015) Jonel Trebicka et al. GUT
- Statin use and non-alcoholic steatohepatitis in at risk individuals
- (2015) Paola Dongiovanni et al. JOURNAL OF HEPATOLOGY
- Seven weeks of Western diet in apolipoprotein-E-deficient mice induce metabolic syndrome and non-alcoholic steatohepatitis with liver fibrosis
- (2015) Robert Schierwagen et al. Scientific Reports
- Pleiotropic Effects of Statins in Atherosclerotic Disease: Focus on the Antioxidant Activity of Atorvastatin
- (2014) Elisabetta Profumo et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins
- (2014) Giusi Marrone et al. GUT
- Glucagon-Induced Acetylation of Foxa2 Regulates Hepatic Lipid Metabolism
- (2013) Ferdinand von Meyenn et al. Cell Metabolism
- Are statins ‘IDEAL’ for non-alcoholic fatty liver disease?
- (2013) Vasilios G. Athyros et al. CURRENT MEDICAL RESEARCH AND OPINION
- The global NAFLD epidemic
- (2013) Rohit Loomba et al. Nature Reviews Gastroenterology & Hepatology
- Simvastatin Ameliorates Liver Fibrosis via Mediating Nitric Oxide Synthase in Rats with Non-Alcoholic Steatohepatitis-Related Liver Fibrosis
- (2013) Wei Wang et al. PLoS One
- Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology
- (2013) Ingmar Mederacke et al. Nature Communications
- Serum markers of the extracellular matrix remodeling reflect antifibrotic therapy in bile-duct ligated rats
- (2013) Robert Schierwagen et al. Frontiers in Physiology
- The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial–stellate cell deactivation induced by statins
- (2012) Giusi Marrone et al. JOURNAL OF HEPATOLOGY
- Atorvastatin inhibits proliferation and apoptosis, but induces senescence in hepatic myofibroblasts and thereby attenuates hepatic fibrosis in rats
- (2012) Sabine Klein et al. LABORATORY INVESTIGATION
- Diabetes Adversely Affects Macrophages During Atherosclerotic Plaque Regression in Mice
- (2011) S. Parathath et al. DIABETES
- Atheroprotection via cannabinoid receptor-2 is mediated by circulating and vascular cells in vivo
- (2011) Friedrich Felix Hoyer et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts
- (2011) Jonel Trebicka et al. LIVER INTERNATIONAL
- Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis
- (2010) Dina G. Tiniakos et al. Annual Review of Pathology-Mechanisms of Disease
- CB1 receptor inhibition leads to decreased vascular AT1 receptor expression, inhibition of oxidative stress and improved endothelial function
- (2010) Vedat Tiyerili et al. BASIC RESEARCH IN CARDIOLOGY
- Clostridium difficile Toxin–Induced Inflammation and Intestinal Injury Are Mediated by the Inflammasome
- (2010) Jeffrey Ng et al. GASTROENTEROLOGY
- Endothelial expression of transcription factor Kruppel-like factor 2 and its vasoprotective target genes in the normal and cirrhotic rat liver
- (2010) J. Gracia-Sancho et al. GUT
- Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH
- (2010) Yuki Kimura et al. JOURNAL OF GASTROENTEROLOGY
- Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells
- (2010) Jonel Trebicka et al. JOURNAL OF HEPATOLOGY
- Prescribing Statins to Patients with Nonalcoholic Fatty Liver Disease: Real Cardiovascular Benefits Outweigh Theoretical Hepatotoxic Risk
- (2009) P. Riley et al. Cardiovascular Therapeutics
- Inhibition of RhoA or Rac1? Mechanism of Cholesterol-Independent Beneficial Effects of Statins
- (2009) Yoshiyuki Rikitake et al. CIRCULATION JOURNAL
- Simvastatin Lowers Portal Pressure in Patients With Cirrhosis and Portal Hypertension: A Randomized Controlled Trial
- (2009) Juan G. Abraldes et al. GASTROENTEROLOGY
- Role of β3-adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosis
- (2009) Jonel Trebicka et al. HEPATOLOGY
- A Pilot Study Using Simvastatin in the Treatment of Nonalcoholic Steatohepatitis
- (2009) Austin Nelson et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects
- (2008) Ki Chul Sung et al. ATHEROSCLEROSIS
- The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis
- (2008) A. Blum et al. ATHEROSCLEROSIS
- Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia
- (2008) Hideyuki Hyogo et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Structure and mode of action of clostridial glucosylating toxins: the ABCD model
- (2008) Thomas Jank et al. TRENDS IN MICROBIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More